Assessing Europe's policy readiness to confront the MASLD/MASH public health threat.
Lazarus JV, White TM, Agirre-Garrido L, Abeysekera KWM, Brennan PN, Brůha R, Buttigieg S, Carrieri P, Cortez-Pinto H, Flisiak R, Francque SMA, Frühbeck G, Gheorghe LS, Hagström H, Holleboom AG, Ivanov K, Jensterle M, Jepsen P, Kupčinskas J, Mark HE, Mauricio D, Bibi SM, Moreno C, Mrzljak A, Papanicolaou E, Papp M, Papatheodoridis G, Peck-Radosavljevic M, Pugliese N, Ryan JD, Ribeiro RT, Salupere R, Skladany L, Tolmane I, Yki-Järvinen H, Schattenberg JM, Pericàs JM; European MASLD collaborator group.
Lazarus JV, et al.
Lancet Reg Health Eur. 2026 May 25;65:101713. doi: 10.1016/j.lanepe.2026.101713. eCollection 2026 Jun.
Lancet Reg Health Eur. 2026.
PMID: 42266904
Free PMC article.
Review.